BhaskarSrivastavaMDPhD
Dermatology • Worcester, MAAssistant Clinical Professor of Dermatology, Yale University School of Medicine
Dr. Srivastava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
425 Lake Ave N
Worcester, MA 01605
Education & Training
Yale-New Haven Medical CenterResidency, Dermatology, 2008 - 2011- Yale-New Haven Medical CenterInternship, Internal Medicine, 2007 - 2008
Perelman School of Medicine at the University of PennsylvaniaClass of 2007
Certifications & Licensure
PA State Medical License 2016 - 2024
MA State Medical License 2015 - 2018
CT State Medical License 2011 - 2017- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial.April W Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman
JAMA Dermatology. 2024-10-01 - 14 citationsDiscovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279.Silvana Leit, Jeremy Greenwood, Samantha Carriero, Sayan Mondal, Robert Abel
Journal of Medicinal Chemistry. 2023-08-10 - 15 citationsReduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysis.Richard G. Langley, Yves Poulin, Bhaskar Srivastava, Kimberly Parnell Lafferty, Steven Fakharzadeh
Journal of the American Academy of Dermatology. 2021-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
